The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Kintara Therapeutics, Inc(NASDAQ:KTRA) 
Kintara Therapeutics, Inc., a clinical stage drug development company, focuses on developing and commercializing anti-cancer therapies to treat cancer patients. It is developing two late-stage, Phase III-ready therapeutics, including VAL-083, a DNA-targeting agent for the treatment of drug-resistant...
Website: https://www.kintara.com/
Founded: 2009
CEO: Saiid Zarrabian
Sector: Manufacturing
Industry: Polish and Other Sanitation Good Manufacturing
Kintara Therapeutics Number of Twitter Followers
Kintara Therapeutics Days Payable Outstanding ttm (DPO)
Kintara Therapeutics Op Cashflow Per Share ttm
Kintara Therapeutics Free Cashflow Per Share ttm
Kintara Therapeutics Cash Per Share ttm
Kintara Therapeutics (GAAP) P/E ratio ttm
Kintara Therapeutics P/B ratio ttm
No extra charts and metrics for this ticker.